Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Layilin augments integrin activation to promote antitumor immunity

The Journal of Experimental Medicine(2020)10.1084/jem.20192080Source: DataRank Database

Layilin augments integrin activation to promote antitumor immunity is a research paper published in The Journal of Experimental Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 69 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access69 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.21)OA: bronzeTopics (65)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

J. Moreau ORCID,Jeff E. Glasgow ORCID,Devi P Boda ORCID,Mariela Pauli ORCID,Victoire Gouirand ORCID

Live enrichment

PubMed:32539073 PMC:PMC7478725 OpenAlex:https://openalex.org/W3034758733

Diabetes Research Center

Grant: P30 DK063720

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: R21AR72195

Human Frontiers Science Program

Grant: LT000183/2018-L

National Institutes of Health

Grant: 5T32DK007573

NIAID NIH HHS

Grant: T32 AI007334

NIDDK NIH HHS

Grant: T32 DK007573

NIAMS NIH HHS

Grant: R21 AR072195

NHGRI NIH HHS

Grant: T32 HG002295

National Institutes of Health

FWCI

2.21

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.rupress.org/terms/

journalhttps://rupress.org/jem/article-pdf/217/9/e20192080/1045393/jem_20192080.pdf

publisherhttps://rupress.org/jem/article-pdf/217/9/e20192080/1045393/jem_20192080.pdf

publisherhttps://rupress.org/jem/article-pdf/doi/10.1084/jem.20192080/1780578/jem_20192080.pdf

journalhttps://doi.org/10.1084/jem.20192080

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32539073

Fields of Study

CAR-T cell therapy researchT-cell and B-cell ImmunologyImmune Cell Function and InteractionAnimalsCD8-Positive T-LymphocytesCarrier ProteinsCell AdhesionCell ProliferationClone CellsCytokinesCytotoxicity, ImmunologicGene EditingHumansImmunityIntegrinsLectins, C-TypeLymphocyte ActivationLymphocyte Function-Associated Antigen-1Lymphocytes, Tumor-InfiltratingMelanomaMembrane GlycoproteinsMice, Inbred C57BLNeoplasm MetastasisNeoplasmsProtein BindingTalin

MeSH Terms

Gene EditingAnimalsCarrier ProteinsCell AdhesionClone CellsCytotoxicity, ImmunologicHumansImmunityLymphocyte ActivationMelanomaMembrane GlycoproteinsMice, Inbred C57BLNeoplasm MetastasisNeoplasmsProtein BindingIntegrinsLymphocyte Function-Associated Antigen-1CytokinesLymphocytes, Tumor-InfiltratingTalinCD8-Positive T-LymphocytesLectins, C-TypeCell Proliferation

Keywords

Cytotoxic T cellCD8BiologyCell biologyIntegrinEx vivoZAP70Immune systemT cellInterleukin 21Cancer researchIn vivoImmunologyIn vitroReceptorBiochemistry

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of HWJMSC-EVs promote cartilage regeneration and repair via the ITGB1/TGF-β/Smad2/3 axis mediated by microfractures

10.6084/m9.figshare.26705805.v1figshare

Additional file 1 of HWJMSC-EVs promote cartilage regeneration and repair via the ITGB1/TGF-β/Smad2/3 axis mediated by microfractures

10.6084/m9.figshare.26705805figshare